Tag Archives: NASDAQ:RDUS

Radius Health Gets a Buy Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Mara Goldstein maintained a Buy rating on Radius Health (NASDAQ: RDUS) yesterday and set a price target of $58. The company’s shares closed yesterday at $31.77. Goldstein observed: “TYMLOS Growing the Market. RDUS reported 1Q18 sales of

Radius Health Receives a Buy from Morgan Stanley

Morgan Stanley analyst Matthew Harrison maintained a Buy rating on Radius Health (NASDAQ: RDUS) today and set a price target of $59. The company’s shares closed yesterday at $33.83. According to TipRanks.com, Harrison is a 4-star analyst with an average

Radius Health Gets a Buy Rating from Morgan Stanley

Morgan Stanley analyst Matthew Harrison maintained a Buy rating on Radius Health (NASDAQ: RDUS) today and set a price target of $61. The company’s shares closed yesterday at $37.54. According to TipRanks.com, Harrison is a 5-star analyst with an average

Cantor Fitzgerald Reaffirms Their Buy Rating on Radius Health

In a report released yesterday, Mara Goldstein from Cantor Fitzgerald maintained a Buy rating on Radius Health (NASDAQ: RDUS), with a price target of $58. The company’s shares closed yesterday at $33.86. According to TipRanks.com, Goldstein is a 1-star analyst

Analysts Are Bullish on These Healthcare Stocks: RDUS, ICPT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Radius Health (NASDAQ: RDUS) and Intercept Pharma (NASDAQ: ICPT) with bullish sentiments. Radius Health (NASDAQ: RDUS) Canaccord Genuity analyst John Newman maintained

Radius Health Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Carol Werther reiterated a Buy rating on Radius Health (NASDAQ: RDUS) yesterday and set a price target of $63. The company’s shares closed yesterday at $36.47. According to TipRanks.com, Werther is a 5-star analyst with an average